Article Figures & Data
Tables
Ruptured Unruptured All Cerecyte (n = 109) (No.) (%) Bare Platinum (n = 112) (No.) (%) P Cerecyte (n = 119) (No.) (%) Bare Platinum (n = 123) (No.) (%) P Cerecyte (n = 228) (No.) (%) Bare Platinum (n = 235) (No.) (%) P mRS 0 64 (58.7) 62 (55.4)a 93 (78.2)a 100 (81.3)a 157 (68.9) 162 (68.9) mRS 1 31 (28.4)b 43 (38.4)b 17 (14.3) 16 (13.0) 48 (21.1) 59 (25.1) mRS 2 8 (7.3) 5 (4.5) 4 (3.4) 7 (5.7) 12 (5.3) 12 (5.1) mRS 3 2 (1.8) 0 (0.0) 3 (2.5) 0 (0.0) 5 (2.2) 0 (0.0) mRS 4 1 (0.9) 1 (0.9) 1 (0.8) 0 (0.0) 2 (0.9) 1 (0.4) mRS 5 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) Deathc 3 (2.8) 1 (0.9) 1 (0.8) 0 (0.0) 4 (1.8) 1 (0.4) mRS ≥3, including deathd 6 (5.5) 2 (1.8) .070 5 (4.2) 0 (0.0) 0.011 11 (4.8) 2 (0.9) .0049 -
↵a Four patients with mRS 0 had first follow-up at >12 months (14, 20, 21, and 22 months).
-
↵b Two patients with mRS 1 had first follow-up at >12 months (13 and 14 months).
-
↵c Causes of death: in-hospital: 1 delayed cerebral ischemia due to vasospasm, 1 postprocedural acute rebleed. Postdischarge: 1 pulmonary embolism, 1 coronary disease, and 1 respiratory.
-
↵d P values are for 1-sided Blackwelder tests.
-
Neurological Status at Discharge Cerecyte (n = 114) (No.) (%) Bare Platinum (n = 119) (No.) (%) P WFNS 1 98 (86.0) 102 (85.7) WFNS 2 10 (8.8) 16 (13.4) WFNS 3 1 (0.9) 1 (0.8) WFNS 4 3 (2.6) 0 (0.0) Death 2 (1.8) 0 (0.0) WFNS ≥3, including death 6 (5.3) 1 (0.8) .025 Destination at discharge Home 83 (72.8) 94 (79.0) Other hospital 26 (22.8) 23 (19.3) Rehabilitation 3 (2.6) 2 (1.7) Death 2 (1.8) 0 (0.0) Home vs rest 83 (72.8) 94 (79.0) .13 Length of stayb (median) (IQR) 6 (3–11) 7 (3–11) .54 Neurological Status at Discharge Cerecyte (n = 133) (No.) (%) Bare Platinum (n = 131) (No.) (%) P mRS 0 108 (81.2) 108 (82.4) mRS 1 23 (17.3) 19 (14.5) mRS 2 2 (1.5) 4 (3.1) mRS ≥3 0 (0.0) 0 (0.0) Death 0 (0.0) 0 (0.0) mRS ≥3, including death 0 (0.0) 0 (0.0) – Destination at discharge Home 131 (98.5) 129 (98.5) Other hospital 1 (0.8) 2 (1.5) Rehabilitation 1 (0.8) 0 (0.0) Death 0 (0.0) 0 (0.0) Home vs rest 131 (98.5) 129 (98.5) .51 Length of stayb (median) (IQR) 1 (1–2) 2 (1–3) .49
In this issue
Jump to section
Related Articles
Cited By...
- Evaluation of effectiveness and safety of the CorPath GRX robotic system in endovascular embolization procedures of cerebral aneurysms
- A Pragmatic Randomized Trial Comparing Surgical Clipping and Endovascular Treatment of Unruptured Intracranial Aneurysms
- A Pragmatic Randomized Trial Comparing Surgical Clipping and Endovascular Treatment of Unruptured Intracranial Aneurysms
- China Intracranial Aneurysm Project (CIAP): protocol for a prospective cohort study of interventional treatment and craniotomy for unruptured aneurysms
- How safe and effective are existing treatments for wide-necked bifurcation aneurysms? Literature-based objective performance criteria for safety and effectiveness
- Hydrogel versus Bare Platinum Coils in Patients with Large or Recurrent Aneurysms Prone to Recurrence after Endovascular Treatment: A Randomized Controlled Trial
- Bioactive versus bare platinum coils for the endovascular treatment of intracranial aneurysms: systematic review and meta-analysis of randomized clinical trials
- Inter- and Intrarater Agreement on the Outcome of Endovascular Treatment of Aneurysms Using MRA
- Periprocedural safety of aneurysm embolization with the Medina Coil System: the early human experience
- Enhancing Brain Lesions after Endovascular Treatment of Aneurysms
- Patients Prone to Recurrence after Endovascular Treatment: Periprocedural Results of the PRET Randomized Trial on Large and Recurrent Aneurysms
- Effects of Circle of Willis Anatomic Variations on Angiographic and Clinical Outcomes of Coiled Anterior Communicating Artery Aneurysms
- Bioactive versus Bare Platinum Coils in the Treatment of Intracranial Aneurysms: The MAPS (Matrix and Platinum Science) Trial
- A history of detachable coils: 1987-2012
- Comparative Effectiveness of Ruptured Cerebral Aneurysm Therapies: Propensity Score Analysis of Clipping versus Coiling
- Differences in the Angiographic Evaluation of Coiled Cerebral Aneurysms between a Core Laboratory Reader and Operators: Results of the Cerecyte Coil Trial
- Endovascular Therapy for Asymptomatic Unruptured Intracranial Aneurysms: JR-NET and JR-NET2 Findings
- Coil Embolization versus Clipping for Ruptured Intracranial Aneurysms: A Meta-Analysis of Prospective Controlled Published Studies
- Best Evidence: Comments on Meta-Analysis of Coiling versus Clipping
- The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?
- Safety and Efficacy of Neuroform for Treatment of Intracranial Aneurysms: A Prospective, Consecutive, French Multicentric Study
- Cerecyte Coil Trial: Angiographic Outcomes of a Prospective Randomized Trial Comparing Endovascular Coiling of Cerebral Aneurysms With Either Cerecyte or Bare Platinum Coils
- Back to the Tower of Babel: Comparing Outcomes from Aneurysm Trials